Related News

5 quick exercises to help build muscle

The frantic daily routine of our lives requires us to be more active than ever. And why do you need an expensive gym membership to get muscle? If you are

How to remove yellow stains from teeth: 3 tips that always work

Yellow teeth may seem like an inevitability of life, be it from drinking coffee, savoring red wine, or mere aging. Professional teeth whitening is an option, but there are those

This simple pink detox drink is your one-stop solution for glowing skin

(Image Credits: Pinterest) With the swift change from winter to summer, we experience dull and dry skin with a darker skin tone, which is not a sun tan. Have you

New mummy Kiara Advani’s stunning maternity fashion

Effortless elegance in everyday wearNew mom Kiara Advani is redefining maternity fashion with a seamless blend of comfort, glamour, and personal style, setting new trends for moms-to-be across India. During

5 parenting mistakes that unconsciously promote gender bias in children

A major external source that teaches children negative stereotypes is TV, films and books. Instead of shutting down your child’s exposure to media altogether, seek books and media which are

5 fruits one must have on an empty stomach for maximum benefits

Oranges and other fruits with high levels of vitamin C boost the immune system and have anti-inflammatory properties. Oranges are rich in nutrients like vitamin B, magnesium, potassium, and copper.

Anne Wojcicki to buy back 23andMe and its data for $305 million

Word Count: 319 | Estimated Reading Time: 2 minutes

23andMe Founder and Board Member Anne Wojcicki speaks during a House Committee on Oversight and Government Reform hearing on June 10, 2025 in Washington, DC.

Andrew Harnik | Getty Images

Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, out bid Regeneron Pharmaceuticals, the company announced on Friday.

TTAM will acquire substantially all of 23andMe’s assets for $305 million, including its Personal Genome Service and Research Services business lines as well as telehealth subsidiary Lemonaid Health. It’s a big win for Wojcicki, who stepped down from her role as CEO when 23andMe filed for for Chapter 11 bankruptcy protection in March.

Last month, Regeneron announced that it would purchase most of 23andMe’s assets for $256 million after it came out on top during a bankruptcy auction. But Wojcicki submitted a separate $305 million bid through TTAM and pushed to reopen the auction. TTAM is an acronym for the first letters of 23andMe, according to the Wall Street Journal.

“I am thrilled that TTAM Research Institute will be able to continue the mission of 23andMe to help people access, understand and benefit from the human genome,” Wojcicki said in a statement.

23andMe gained popularity because of its at-home DNA testing kits that gave customers insight into their family histories and genetic profiles. The five-time CNBC Disruptor 50 company went public in 2021 via a merger with a special purpose acquisition company. At its peak, 23andMe was valued at around $6 billion.

The company struggled to generate recurring revenue and stand up viable research and therapeutics businesses after going public, and it’s been plagued by privacy concerns since hackers accessed the information of nearly 7 million customers in 2023.

TTAM’s acquisition is still subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri.

WATCH: Regeneron CEO on 23andMe bid: Trying to balance individual privacy with biotech & genetics research